Self‐Microemulsifying Drug Delivery System: Liquid‐Filled Gelatin Capsules of Atorvastatin and Ezetimibe
Advances in Pharmacological and Pharmaceutical Sciences · 2026-01 · 2026 (1)
DOI: 10.1155/adpp/8642343 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Pharmacological and Pharmaceutical Sciences, online erschienen am 04.11.2026. Verfasst von Yara Nabeel Al-Salhi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Department Faculty of Pharmacy, Nursing and Health Professions Birzeit University P.O. Box 14 Birzeit West Bank State of Palestine birzeit.e…. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Birzeit University.
Abstract (Originalsprache)
Atorvastatin (ATV) and ezetimibe (EZE) are BCS Class II drugs with low oral bioavailability (14% and 35%, respectively) attributed to poor aqueous solubility and extensive first‐pass metabolism. Although the two drugs act synergistically to lower cholesterol, their combination into a single delivery system is complicated by differing physicochemical properties. This study aimed to develop and characterize a self‐microemulsifying drug delivery system (SMEDDS) coloaded with ATV and EZE, encapsulated in an Empo Caps LP + size 00 capsule, to improve their dissolution and permeability. Pseudoternary phase diagrams were constructed to identify microemulsion regions, and candidate formulations were screened by droplet size, polydispersity index, refractive index, and viscosity. Four formulations (ME#22, ME#26, ME#31, and ME#35) met the physical acceptance criteria, including a polydispersity index (PDI) within its theoretically valid 0–1 range; a fifth trial (ME#12) was excluded on this basis. Formula 31—containing 14.96% triacetin, 39.89% Tween 80%, and 19.94% PEG 400 (oil:surfactant/cosurfactant ratio 2:8; surfactant:cosurfactant ratio 2:1)—showed the highest drug loading (ATV 3.95 ± 0.35 mg/mL; EZE 3.04 ± 0.06 mg/mL), a droplet size of 74.15 ± 1.68 nm, PDI of 0.34 ± 0.02, refractive index of 1.372, and viscosity of 310 ± 9.58 cP, with assay values of 104.6% (ATV) and 104.9% (EZE). This formulation demonstrated faster in vitro dissolution than the commercial reference product (Atozet) across all tested media and significantly greater ex vivo intestinal permeability than plain drug suspension ( p < 0.05 from 90 min onward). In conclusion, an ATV‐/EZE‐loaded SMEDDS encapsulated in an Empo Caps LP + size 00 capsule was successfully developed and showed improved in vitro dissolution and ex vivo permeability relative to the marketed product, supporting its potential as an alternative oral delivery strategy for this drug combination.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pharmacy Department Faculty of Pharmacy, Nursing and Health Professions Birzeit University P.O. Box 14 Birzeit West Bank State of Palestine birzeit.edu.
- Department of Chemistry at Al-Quds University Abu Dis State of Palestine.
ORCID-Profile: Hani Naseef, Moammal Qurt, Abdallah Damin Abukhalil, Abdullah K Rabba, Fuad Al-Rimawi
Förderung
- Birzeit University
Zitieren
APA
Al-Salhi, Y. N., Naseef, H., Qurt, M., Abukhalil, A. D., Rabba, A. K., Sabri, I., & Al-Rimawi, F. (2026). Self‐Microemulsifying Drug Delivery System: Liquid‐Filled Gelatin Capsules of Atorvastatin and Ezetimibe. Advances in Pharmacological and Pharmaceutical Sciences, 2026(1). https://doi.org/10.1155/adpp/8642343
Vancouver
Al-Salhi YN, Naseef H, Qurt M, Abukhalil AD, Rabba AK, Sabri I, et al. Self‐Microemulsifying Drug Delivery System: Liquid‐Filled Gelatin Capsules of Atorvastatin and Ezetimibe. Advances in Pharmacological and Pharmaceutical Sciences. 2026;2026(1). doi:10.1155/adpp/8642343
BibTeX
@article{AlSalhi2026,
author = {Al-Salhi, Yara Nabeel and Naseef, Hani and Qurt, Moammal and Abukhalil, Abdallah Damin and Rabba, Abdullah K and Sabri, Israr and Al-Rimawi, Fuad},
title = {Self‐Microemulsifying Drug Delivery System: Liquid‐Filled Gelatin Capsules of Atorvastatin and Ezetimibe},
journal = {Advances in Pharmacological and Pharmaceutical Sciences},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/adpp/8642343}
}
EUVIMED